AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
MPN highlights at ASH 2022: novel agents, combinations & the role of immunotherapy
VJHemOnc Podcast
Choosing Between Combination Therapy and Novel Jack Inhibitors in Myelofibrosis: balancing side effects and positive results
Analyzing the pros and cons of upfront combination therapy versus novel Jack inhibitors in the frontline setting for myelofibrosis patients, including potential side effects, treatment selection, and limitations of biomarkers.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode